A prospective double-blind randomized control trial ( RCT ) to evaluate the benefit of a combinatorial , five gene pharmacogenomic test and interpretive report ( GeneSight ) for the management of psychotropic medications used in the treatment of major depression in an outpatient psychiatric practice .